These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2441267)

  • 21. An assay for the detection of human anti-murine immunoglobulins in the presence of CA125 antigen.
    Moseley KR; Knapp RC; Haisma HJ
    J Immunol Methods; 1988 Jan; 106(1):1-6. PubMed ID: 3422257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies against human solid tumors.
    Burtin P; Nardelli J
    Bull Cancer; 1983; 70(2):108-12. PubMed ID: 6191805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
    Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
    Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
    [No Abstract]   [Full Text] [Related]  

  • 24. Enzyme-linked immunosorbent assay of antibodies to adult T-cell leukemia-associated antigens.
    Taguchi H; Sawada T; Fujishita M; Morimoto T; Niiya K; Miyoshi I
    Gan; 1983 Apr; 74(2):185-7. PubMed ID: 6345253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection.
    Desai PR; Ujjainwala LH; Carlstedt SC; Springer GF
    J Immunol Methods; 1995 Dec; 188(2):175-85. PubMed ID: 8551046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated glycolipid antigens defined by monoclonal antibodies.
    Hakomori S
    Bull Cancer; 1983; 70(2):118-26. PubMed ID: 6191806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.
    Hirohashi S; Clausen H; Yamada T; Shimosato Y; Hakomori S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7039-43. PubMed ID: 2413456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New carbohydrate tumor markers.
    Itzkowitz SH; Kim YS
    Gastroenterology; 1986 Feb; 90(2):491-4. PubMed ID: 2416629
    [No Abstract]   [Full Text] [Related]  

  • 29. [Different expressions of various epitopes of the Thomsen-Friedenreich antigen in breast cancer cells. Immunohistochemical study with monoclonal antibodies against asialoglycophorin A].
    Bein G; Poschmann A; Seitz RC; Böcker W
    Verh Dtsch Ges Pathol; 1985; 69():218-21. PubMed ID: 2420088
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunohistochemical and radiologic study of the accumulation of antibodies to the beta-1-MA antigen in human tumors transplanted into athymic mice].
    Pugachev KK; Aleksandr SK; Fidler LM; Revazova ES; Shimbireva IB
    Eksp Onkol; 1989; 11(1):50-3. PubMed ID: 2466632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CA-125: An evaluation.
    Nuss R; Swor MG; Benrubi MD
    J Fla Med Assoc; 1987 May; 74(5):329-32. PubMed ID: 2440975
    [No Abstract]   [Full Text] [Related]  

  • 32. IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival.
    Kurtenkov O; Klaamas K; Rittenhouse-Olson K; Vahter L; Sergejev B; Miljukhina L; Shljapnikova L
    Exp Oncol; 2005 Jun; 27(2):136-40. PubMed ID: 15995632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients.
    Lian LJ; Hu XF; Liu WS; Wu AJ
    Chin Med J (Engl); 1986 Sep; 99(9):721-6. PubMed ID: 2433106
    [No Abstract]   [Full Text] [Related]  

  • 34. Preparation of asialo-agalacto-glycophorin A for screening of anti-Tn antibodies.
    Koizumi T; Matsumoto-Takasaki A; Nakada H; Nakata M; Fujita-Yamaguchi Y
    Biosci Trends; 2010 Dec; 4(6):308-11. PubMed ID: 21248428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiotypes of pre-existing human anti-carcinoma anti-T and anti-Tn antibodies.
    Zanetti M; Lenert G; Springer GF
    Int Immunol; 1993 Feb; 5(2):113-9. PubMed ID: 7680895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tn-syndrome.
    Berger EG
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):255-68. PubMed ID: 10571017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of humoral and cell-mediated immunity in human melanoma.
    Mukherji B; Nathanson L; Clark DA
    Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
    [No Abstract]   [Full Text] [Related]  

  • 38. Tn epitope (N-acetyl-D-galactosamine alpha-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness.
    Springer GF
    Mol Immunol; 1989 Jan; 26(1):1-5. PubMed ID: 2467192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpretation of the common tumour antigen (CTA)--an antigen present on all human malignant tumour cells and suspected of mediating malignant growth of cells.
    Kast RE
    Arch Geschwulstforsch; 1977; 47(3):251-8. PubMed ID: 907445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.